Pharmaceutical industry in Kazakhstan. Pharmacy services презентация

Introduction.
Medicines are socially important products necessary for the population. Of course, if possible, it should be produced domestically. After all, this is how their availability for patients is ensured, especially when it comes to generics, which are cheaper than original drugs. Here it is very important to take into account that foreign manufacturers are far from always ready to immediately bring the drug to the Kazakhstani market after the expiration of the patent protection period (especially in today's conditions of complex and rather strict regulation), and if drugs were supplied in full from abroad, for our patients they would become available years later.

For 9 months, enterprises issue products worth 160.4 billion tenge
In January-September 2021, Kazakh pharmaceutical companies purchased products for 160.4 billion tenge (IFO - 138.1%). In physical terms, growth is maintained in almost all types of pharmaceutical products: medicines containing hormones (+70.4%, to 169.4 tons), medicines containing antibiotics (+8.2%, to 1,444 tons), substances containing alkaloids . (+5%, up to 27.3 thousand tons), dressing materials (+2 times, up to 165 tons). This business information center Kapital.kz was informed by the press service of QazIndustry.

In total, in 2020 the company completed production for 141.9 billion tenge. industrial production, which shows real growth, amounted to 147.3%.

The increase in production can be attributed to the high demand for medicines due to the pandemic. In the commodity group “medicines containing alkaloids”, the production of medicines containing vitamins and provitamins increased by 70%, medicines containing pure and mixed products, by 13%, heart remedies by 3%.

New production
QazIndustry notes that the pharmaceutical industry is associated with a dynamically developing sector of the economy. So, in 2021, Karaganda region entered the Leaders on the occasion of the episode for the first time.

New production
Due to new production for 9 months after the start of production of pharmaceutical products for 73.9 billion tenge (vaccine against the disease (Sputnik V), drugs for the treatment of diabetes, drugs for the treatment of heart attack and stroke, drugs for the treatment of rare diseases).

“Domestic producers for increased demand should pay attention to growing opportunities in special cases. Thus, drugs for the treatment of diseases, diabetes, blood diseases, organ diseases, diseases of the genitourinary system, digestive organs, as well as vaccines for people, anti-inflammatory drugs and antipyretic drugs are most in demand in the country,” QazIndustry analysts say.

What is important for Kazakhstani producers at today's event?
The Kazakh pharmaceutical market is close to saturation. Therefore, for continuous development, it is necessary to master the production of new products and expand our presence in foreign markets. These are two main directions, without further development of the domestic pharmaceutical industry it is impossible. However, this, of course, requires conditions. First, a favorable, stable economic and regulatory environment. Secondly, it is support of two directions. It will be income growth hygiene in management.

Pharmacy
In 2022, a significant increase in the volume and the launch of large investment projects (modernization of Chimpharm JSC, launch of new workshops at Dolce LLP, Karaganda Pharmaceutical Complex, etc.) are expected, which can have a positive impact on the development of the industry.